Financials
- Market Capitalization 3.1 B
- Employee 339
- Founded 2016
- CEO N/A
- Website www.veratx.com
- Headquarter Delaware, United States
- FIGI BBG00Q72WYG3
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-7.26
市销率
-2 982.67
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1672 | RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 32.03 USD | -3.58% | -9.11% | +25.41% | +16.94% | 3.15 B USD | ||
| 1673 | ELVN Enliven Therapeutics, Inc. - Common Stock | 51.73 USD | +1.69% | +2.76% | +21.69% | +150.39% | 3.15 B USD | ||
| 1710 | CLDX Celldex Therapeutics, Inc. - Common Stock | 38.17 USD | -0.93% | -3.37% | +20.37% | +40.12% | 3.00 B USD | ||
| 1758 | IRON Disc Medicine, Inc. - Common Stock | 75.01 USD | -1.28% | -4.80% | +8.62% | +29.35% | 2.87 B USD |